![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07K 16/28 | (2006.01) |
G01N 33/574 | (2006.01) | ||
G01N 33/82 | (2006.01) |
(11) | Number of the document | 2731972 |
(13) | Kind of document | T |
(96) | European patent application number | 12736054.3 |
Date of filing the European patent application | 2012-07-13 | |
(97) | Date of publication of the European application | 2014-05-21 |
(45) | Date of publication and mention of the grant of the patent | 2017-12-20 |
(46) | Date of publication of the claims translation | 2018-03-26 |
(86) | Number | PCT/US2012/046672 |
Date | 2012-07-13 |
(87) | Number | WO 2013/012722 |
Date | 2013-01-24 |
(30) | Number | Date | Country code |
201161508444 P | 2011-07-15 | US | |
201261604412 P | 2012-02-28 | US | |
201261604954 P | 2012-02-29 | US |
(72) |
O`SHANNESSY, Daniel, John, US
|
(73) |
Eisai R&D Management Co., Ltd.,
6-10, Koishikawa 4-chome Bunkyo-ku, Tokyo 112-8088,
JP
|
(74) |
Genė Ona SRUOGIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
(54) | Antikūnai prieš foliato receptorius alfa ir jų panaudojimas |
ANTI-FOLATE RECEPTOR ALPHA ANTIBODIES AND USES THEREOF |
Payment date | Validity (years) | Amount | |
2025-06-18 | 14 | 289.00 EUR |
2026-07-13 |